View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, June 9 (HealthDay News) -- In patients with coronary artery disease (CAD) who have undergone percutaneous coronary intervention (PCI), subsequent therapy with folic acid/vitamin B12 lowers levels of total plasma homocysteine (tHcy) but does not have a beneficial effect on disease progression, according to a study in the June 1 issue of the American Journal of Cardiology.
Kjetil H. Løland, of the University of Bergen in Norway, and colleagues studied 348 CAD patients who had been randomized to daily oral doses of folic acid, vitamin B12, and vitamin B6 or placebo in a 2 × 2 factorial design. The researchers followed the subjects for a mean 10.5 months, evaluating baseline tHcy and follow-up tHcy and comparing baseline and follow-up angiograms for changes in minimum lumen diameter and diameter stenosis.
The researchers found that the baseline median tHcy level was 10.0 µmol/L, which treatment with folic acid/vitamin B12 reduced by 22 percent. However, follow-up angiograms revealed 309 lesions with a mean −0.16 mm decrease in minimum lumen diameter from baseline, and an increase in diameter stenosis of 4.4 percent. In subsequent analysis, the researchers found folic acid/vitamin B12 treatment was significantly associated with rapid disease progression (odds ratio, 1.84).
"In conclusion, vitamin B treatment showed no beneficial effect on the angiographic progression of CAD, and the post hoc analyses suggested that folic acid/vitamin B12 treatment might promote more rapid progression," the authors write.
The research was a substudy of the Western Norway B Vitamin Intervention Trial, which was funded in part by Alpharma Inc.
Full Text (subscription or payment may be required)
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top